COMP <GO>
CLOV vs FTRE // RETURN ON INVESTED CAPITAL (ROIC)
Clover Health Investments Corp. (Class A) (NASDAQ) VS. Fortrea Holdings Inc. (NASDAQ) • 15-METRIC TALLY: CLOV 6
— FTRE 2
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CLOV
LAST: $4.31 (-3.36%) • MKT CAP: $2.37B
roic
-29.30%
LAST: $20.02 (-5.96%) • MKT CAP: $2.05B
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLOV VS. FTRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLOV | FTRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -29.30% | -35.00% | +5.70 | CLOV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.84% | -0.41% | -2.43 | FTRE | /fcf-yield <GO> |
| Operating Margin | -4.40% | -32.00% | +27.60 | CLOV | /operating-margins <GO> |
| Net Profit Margin | -4.40% | -36.30% | +31.90 | CLOV | /net-margins <GO> |
| Revenue Growth (YoY) | 40.30% | 1.00% | +39.30 | CLOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.62 | 0.45 | +3.17 | CLOV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 46.4 | -0.70 | FTRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.99 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 29.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.37B | $2.05B | $314.5M | CLOV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLOV REV | FTRE REV | CLOV GROSS % | FTRE GROSS % | CLOV FCF | FTRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.92B | $2.72B | — | — | -$69.0M | -$9.1M |
| FY 2024 | $1.37B | $2.70B | — | — | $33.3M | $141.5M |
| FY 2023 | $1.26B | $2.84B | — | — | -$144.7M | $40.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLOV // BETA —
FTRE // BETA 0.99